1)Hasegawa K, Wakino S, Simic P, et al. Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes. Nat Med. 2013; 19: 1496-504
|
|
|
2)Bordone L, Guarente L. Calorie restriction, SIRT1 and metabolism: understanding longevity. Nat Rev Mol Cell Biol. 2005; 6: 298-305
|
|
|
3)Hasegawa K, Wakino S, Hayashi K, et al. Sirt1 protects against oxidative stress-induced renal tubular cell apoptosis by the bidirectional regulation of catalase expression. Biochem Biophys Res Commun. 2008; 372: 51-6
|
|
|
4)Hasegawa K, Wakino S, Hayashi K, et al. Kidney-specific overexpression of Sirt1 protects against acute kidney injury byretaining peroxisome function. J Biol Chem. 2010; 23: 13045-56
|
|
|
5)Wang P, Xu TY, Guan YF, et al. Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide. Cardiovasc Res. 2009; 81: 370-80
|
|
|
6)Bible E. Diabetic nephropathy: Sirt1 attenuates diabetic albuminuria. Nat Rev Nephrol. 2013; 9: 696
|
|
|
7)Nihalani D, Susztak K. Sirt1-Claudin-1 crosstalk regulates renal function. Nat Med. 2013; 19: 1371-2
|
|
|